Blood Vessels News and Research

RSS

Long-haul flights, length of time under anesthesia increase risk of developing blood clots

The prolonged immobility of flight passengers during long-haul air travel increases the risk of developing blood clots, which could prove fatal especially to people whose travel occurs just prior to major surgery, medical researchers report in the current issue of Mayo Clinic Proceedings.

31 May 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

Shock wave therapy shows remarkable results in wound healing and curing myocardial diseases

Effective, non-invasive and practically without side effects - extracorporeal shock wave therapy has demonstrated impressive results not only in orthopedics and traumatology, but also in treating fresh and chronic wounds as well as circulatory disorders of the myocardial muscle.

31 May 2005

Fluorescence device to diagnose atherosclerosis and tumors

In a presentation at the Conference on Lasers and Electro-Optics (CLEO), researchers from Cedars-Sinai Medical Center's Biophotonics Research and Technology Development Laboratory described recent progress on a device that stimulates, collects and measures light emissions from body tissues to diagnose critical atherosclerotic plaques (vulnerable plaques) and aggressive brain tumors.

29 May 2005

New study shows that bypass surgery is more successful than stents in heart surgery

A study of nearly 60,000 patients has found that people with several clogged heart arteries did better if they had bypass surgery rather than a less-drastic procedure in which the blood vessels are propped open with tiny mesh cylinders called stents.

26 May 2005

'Bad' metabolism cloggs up arteries

Scientists are now saying that a 'bad' metabolism may explain why some people who have never smoked and do not have high cholesterol levels suffer from a potentially lethal build-up of plaque in the arteries.

26 May 2005

Direct link between inefficient metabolism and atherosclerosis

An experiment that turned out very differently than expected led scientists at Washington University School of Medicine in St. Louis to the first direct link between inefficient metabolism and atherosclerosis.

26 May 2005

Study shows how COX-2 inhibitors lead to heart disease

University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and stroke.

26 May 2005

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Female lung transplant recipients are significantly more likely to suffer from a type of injury to the transplanted lung called primary graft dysfunction than male lung transplant patients, according to a study presented at the American Thoracic Society International Conference.

25 May 2005

Cyclophosphamide may be a possible therapy for scleroderma

A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.

24 May 2005

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Treatment with warfarin, a medication that prevents blood clotting, may reduce the risk of stroke by more than two-thirds in patients with atrial fibrillation (AF), a condition which places them at high risk of stroke, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005

Anti-inflammatory protein annexin 1 may protect patients from the detrimental effects of severe inflammatory response syndrome

Severe inflammatory response syndrome, or SIRS, occurs when the body's response to an overwhelming infection becomes uncontrolled. The very immune response meant to clear the pathogen and its toxins actually causes damage to the host's own tissues when it goes into overdrive, releasing too many immune signals.

23 May 2005

Risks outweigh benefits of shark cartilage as anti-cancer treatment

As a treatment for advanced cancer, shark cartilage fails to benefit patients and its adverse effects lead to poor compliance.

23 May 2005

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.

20 May 2005

Bacteria in plaque may increase risk for heart attacks

Researchers have found evidence that the amount of bacteria in subgingival plaques, the deep plaques in periodontal pockets and around the teeth, may contribute to an individual's risk of a heart attack, according to two studies appearing the Journal of Periodontology.

20 May 2005

Two out of three Americans with type-2 diabetes do not have their disease under control

According to a new survey two out of three Americans with type-2 diabetes do not have their disease under control and are putting themselves at risk of early deaths from stroke, heart attack or kidney failure as well as blindness and limb loss.

18 May 2005

Advanced breast cancer drug appears effective on multiple targets

An experimental breast cancer drug that simultaneously attacks five tumor targets has halted progression of the disease in a clinical trial for patients with advanced disease.

18 May 2005

Tumor vasculature has become an attractive target in the treatment of cancer.

Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

17 May 2005

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Researchers showed that the immune system can brand foreign proteins by chemically modifying their structure, and that these modifications increased the chances that cells known as lymphocytes would recognize the trespassers and attack them.

17 May 2005

Blood Vessels News and Research

Long-haul flights, length of time under anesthesia increase risk of developing blood clots

New approach to inhibiting blood vessel growth or angiogenesis

Targepeutics issued new U.S patent

Shock wave therapy shows remarkable results in wound healing and curing myocardial diseases

Fluorescence device to diagnose atherosclerosis and tumors

New study shows that bypass surgery is more successful than stents in heart surgery

'Bad' metabolism cloggs up arteries

Direct link between inefficient metabolism and atherosclerosis

Study shows how COX-2 inhibitors lead to heart disease

Female lung transplant recipients more likely to suffer from primary graft dysfunction

Cyclophosphamide may be a possible therapy for scleroderma

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Anti-inflammatory protein annexin 1 may protect patients from the detrimental effects of severe inflammatory response syndrome

Risks outweigh benefits of shark cartilage as anti-cancer treatment

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Bacteria in plaque may increase risk for heart attacks

Two out of three Americans with type-2 diabetes do not have their disease under control

Advanced breast cancer drug appears effective on multiple targets

Tumor vasculature has become an attractive target in the treatment of cancer.

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News